Clinical Trial Update: Basal Bolus of Insulin Aspart Including Insulin NPH and Biphasic Insulin Aspart in Type 2 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a basal-bolus regimen that combines insulin aspart with insulin NPH and a biphasic insulin aspart in type 2 diabetes; the study statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• NovoLog (insulin aspart)
• NovoLog Mix 70/30 (insulin aspart protamine and insulin aspart mix 70/30)
• insulin NPH (insulin NPH)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED